Skip to content
Multidisciplinary Association for Psychedelic Studies – MAPS

Multidisciplinary Association for Psychedelic Studies - MAPS

  • About
    • Our Mission
    • Our History
    • Our Team
    • Community Allies
  • Our Work
    • Advancing Research
    • Changing Policy
    • Evolving Education
    • The Virtual Trip
  • News
    • Updates
    • Newsletter
    • Press Releases
    • MAPS Bulletin
    • MAPS in the Media
    • Newsroom
  • Take Action
    • MAPS Membership
    • Donate
    • Volunteer
    • Careers
    • Community Events
    • Resources
    • Integration Station
    • Music Is the Bridge
  • Store
    • Learning
    • Apparel
    • Accessories
    • Bookshop
Login
  • Donate
0

policy and advocacy

MAPS Analysis of Colorado’s Natural Medicine Health Act: Reviewing Proposition 122/Measure 58

MAPS’ Policy Values Over the last three years since MAPS published our Considerations For the Regulation and Decriminalization of Psychedelic Substances statement, multiple policy approaches to psychedelics …
October 26, 2022

Statement: Biden Administration Plans to Pardon Prior Federal Offenses of Simple Marijuana Possession

Today, the White House released a statement that President Joe Biden “will grant a pardon to all people convicted of simple marijuana possession under federal law” and “urged governors to take similar …
October 6, 2022

Following Landmark Achievement, California Psychedelic Decriminalization Bill Slated for 2023 Reintroduction

Senate Bill 519 would have decriminalized the personal possession of certain psychedelic substances, legalized life-saving public health interventions, and studied future approaches to increasing use of …
September 1, 2022

MAPS, in Coordination with Allies, Assists U.S. Sentencing Commission in Reaching Quorum

United States Sentencing Commission, which establishes and advises Congress on federal sentencing guidelines, reaches first quorum in 3 years and a full slate for first time since 2014 Delayed appointments …
August 17, 2022

Statement: Biden Administration Preparing for Potential FDA Approval of MDMA-Assisted Therapy for PTSD

Yesterday, a letter from the U.S. Department of Health and Human Services was made public describing the Food and Drug Administration’s “anticipated approval…within approximately 24 months” of …
July 27, 2022

Chacruna Institute Releases Guide for Plant Medicine Churches

Chacruna Institute for Psychedelic Plant Medicines is offering Guide to RFRA and Best Practices for Psychedelic Plant Medicine Churches, which gives churches using psychedelic plant medicines as sacrament …
December 21, 2021

California State Senate Takes Step To Dismantle Psychedelic Prohibition

Fifty years after the War on Drugs was officially declared and psychedelic substance prohibition began in contravention of evidence supporting therapeutic use, the California State Senate has taken the …
June 23, 2021

Lawsuit Filed Against the DEA and Attorney General to Compel Issuance of Licenses to Manufacture Marijuana for Clinical Trials and Potential FDA Approval

On the heels of United Nations’ Commission on Narcotic Drugs removal of medical marijuana from the list of most dangerous drugs, lawsuit demands processing and approval of licenses to support research …
December 3, 2020

MAPS’ Policy Statement: Considerations for the Regulation and Decriminalization of Psychedelic Substances

Written by Natalie Lyla Ginsberg, M.S.W., and Ismail Lourido Ali, J.D. MAPS Bulletin Summer 2019: Vol. 29, No. 2 Research Edition Download this article. Since its 1986 inception, Multidisciplinary Association …
September 3, 2019

Statement: Considerations for the Regulation and Decriminalization of Psychedelic Substances

Summary Since its 1986 inception, the Multidisciplinary Association for Psychedelic Studies’ (MAPS’) stated mission has been the development of medical, legal, and cultural contexts for people to benefit …
May 31, 2019

Posts pagination

Newer Posts Page 1 Page 2
Multidisciplinary Association for Psychedelic Studies – MAPS
  • About
    • Our Mission
    • Our History
    • Our Team
    • Financial Reports
    • Careers
    • Refunds & Returns
    • FAQs
    • Privacy Policy
    • Global Affiliates
  • Our Work
    • Psychedelic Fundamentals
    • The Virtual Trip
    • U.S. MDMA Therapy Education
    • Health Equity
    • Policy & Advocacy
  • Advancing Research
    • MDMA
    • Marijuana
    • LSD
    • Ibogaine
    • Ayahuasca
  • News
    • Updates
    • MAPS in the Media
    • MAPS Bulletin
    • MAPS Podcast
    • Monthly Newsletter
    • Press Releases
    • Newsroom
  • Take Action
    • MAPS Membership
    • Donate
    • Participate in a Trial
    • Events
    • Resources

Newsletter Sign Up

  • Facebook
  • Instagram
  • Twitter
  • YouTube
  • LinkedIn
  • Reddit
© 1986 - 2026 Multidisciplinary Association for Psychedelic Studies. All Rights Reserved. Disclaimer | Privacy Policy.
3141 Stevens Creek Blvd #40563, San Jose, CA 95117.
Mail checks to: MAPS P.O. Box 103004 Pasadena, CA 91189-3004.
Proudly powered by WordPress. Hosted by Pressable.

Download our Integration Guide

Just enter your email in order to download our Integration Guide